Wednesday, March 29, 2017

FDA Approves Drug for Primary Progressive Multiple Sclerosis

The FDA approved a Genentech multiple-sclerosis drug called Ocrevus, the first treatment for the most severe type of MS.

from WSJ.com: US Business http://ift.tt/2o7gE4K
via IFTTT

No comments:

Post a Comment